History & Overview Annual Report President's Pages Center News Community Affairs

Make a Gift Yankees Universe Fund Fred's Team Cycle for Survival Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook

Press Releases Information for Journalists News@MSKCC

Manhattan New Jersey Long Island Westchester

Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online

Newly Diagnosed with Lymphoma

Our Team of Experts

Hodgkin Lymphoma

Non-Hodgkin Lymphoma

Our Clinical Trials

Survivorship & Support

Our Lymphoma Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering's current clinical trials for patients with lymphomas. To learn more about a study, choose from the list below.

Hodgkin's Disease
Lymphoma
Non-Hodgkin's Lymphoma

Hodgkin's Disease

A Global Assessment of Medical Morbidities and Quality of Life Among Survivors of Hodgkin's Lymphoma
Straus, David, MD

[Protocol 05-041]
A Phase I/II Study of Clofarabine in Patients with Relapsed T-cell and NK-Cell Lymphomas
Horwitz, Steven, MD

[Protocol 06-065]
A Phase I/II Study of SB-743921 in Patients with Non-Hodgkin's Lymphoma
Gerecitano, John, MD, PhD

[Protocol 07-083]
A Phase I/IIA Study of Pralatrexate and Gemcitabine with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Lymphoma
Horwitz, Steven, MD

[Protocol 07-062]
A Phase II Study of Bendamustine HCl in Relapsed and Primary Refractory Hodgkin's Lymphoma
Moskowitz, Craig, MD

[Protocol 08-041]
A Phase II Trial of Risk-Adapted High-Dose Chemoradiotherapy and Autologous Stem Cell Transplantation for Patients with Relapsed and Primary Refractory Hodgkin's Lymphoma
Moskowitz, Craig, MD

[Protocol 04-047]
A Phase III Study of ABVD with or without Rituximab for Patients with Advanced-Stage Classical Hodgkin Lymphoma with Poor-Risk Features
Portlock, Carol, MD

[Protocol 08-063]
A Study Evaluating the Effectiveness of Leuprolide for Enhancing Immune Function After Autologous Stem Cell Transplantation
Landau, Heather, MD

[Protocol 07-046]
A Study of Salvage Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplant for the Treatment of High-Risk or Relapsed Hodgkin's Lymphoma
Perales, Miguel-Angel, MD

[Protocol 07-147]
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Offit, Kenneth, MD

[Protocol 00-069]
Health-Related Outcomes for Hodgkin's Disease Survivors
Trippett, Tanya, MD

[Protocol 06-140]
Phase I Study of MDX-1401 in Patients with CD30-Positive Refractory/Relapsed Hodgkin's Lymphoma
Horwitz, Steven, MD

[Protocol 07-169]

A Global Assessment of Medical Morbidities and Quality of Life Among Survivors of Hodgkin's Lymphoma
Straus, David, MD

[Protocol 05-041]
A Multicenter Phase I Study of Deforolimus (AP23573) in Pediatric Patients with Advanced Solid Tumors
Pratilas, Christine, MD

[Protocol 08-110]
A Phase I Study of Pralatrexate with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma
Horwitz, Steven, MD

[Protocol 07-146]
A Phase I/II Study of Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Patients with Relapsed/Refractory Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)
Gerecitano, John, MD, PhD

[Protocol 05-103]
A Phase I/II Study of Clofarabine in Patients with Relapsed T-cell and NK-Cell Lymphomas
Horwitz, Steven, MD

[Protocol 06-065]
A Phase I/II Study of SB-743921 in Patients with Non-Hodgkin's Lymphoma
Gerecitano, John, MD, PhD

[Protocol 07-083]
A Phase I/II Study of the Tor Kinase Inhibitor AZD8055 in Patients with Advanced Solid Tumors, Lymphomas, or Endometrial Carcinoma
Aghajanian, Carol, MD

[Protocol 08-093]
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders
O'Reilly, Richard, MD

[Protocol 95-024]
A Phase I/II Trial of Vorinostat in Combination with Cyclophosphamide, Etoposide, Prednisone, and Rituximab for Elderly Patients with Relapsed Diffuse Large B-Cell Lymphoma
Straus, David, MD

[Protocol 08-045]
A Phase I/IIA Study of Pralatrexate and Gemcitabine with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Lymphoma
Horwitz, Steven, MD

[Protocol 07-062]
A Phase I/IIa Study Evaluating ABT-263 in Patients with Relapsed or Refractory Lymphoid Malignancies
Gerecitano, John, MD, PhD

[Protocol 07-048]
A Phase II Study of Dose-Escalated Rituximab and ICE for Patients with Primary Refractory and Poor-Risk Relapsed Aggressive B-cell Non-Hodgkin's Lymphoma Undergoing Second-Line Therapy Prior to Stem Cell Transplantation
Moskowitz, Craig, MD

[Protocol 03-075]
A Phase II Trial of Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplants after a Myeloablative Preparative Regimen for Adult Patients with Lymphohematopoietic Disorders
Jakubowski, Ann, MD, PhD

[Protocol 01-070]
A Phase II Trial of Liposomal Doxorubicin (Doxil^®) Followed by Bexarotene (Targretin^®) in Advanced Cutaneous T-Cell Lymphoma
Straus, David, MD

[Protocol 05-098]
A Phase III Study of ABVD with or without Rituximab for Patients with Advanced-Stage Classical Hodgkin Lymphoma with Poor-Risk Features
Portlock, Carol, MD

[Protocol 08-063]
Biaxin (Clarithromycin)-Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
Portlock, Carol, MD

[Protocol 07-038]
Participation in the National Marrow Donor Program Registry
Kernan, Nancy, MD

[Protocol 90-091]
Risk-Adapted Therapy for Patients With Untreated Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B-Cell Lymphoma
Moskowitz, Craig, MD

[Protocol 08-026]

Non-Hodgkin's Lymphoma

A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and Stem Cell Transplantation in Patients with B-cell Non-Hodgkin's Lymphoma
Castro-Malaspina, Hugo, MD

[Protocol 06-150]
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies
Barker, Juliet, MBBS

[Protocol 06-066]
A Phase I Study of AZD4877 in Patients with Advanced Solid Tumors
Schwartz, Gary, MD

[Protocol 07-052]
A Phase I Study of Pralatrexate with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Cutaneous T-cell Lymphoma
Horwitz, Steven, MD

[Protocol 07-146]
A Phase I/II Study of SB-743921 in Patients with Non-Hodgkin's Lymphoma
Gerecitano, John, MD, PhD

[Protocol 07-083]
A Phase I/II Trial of Vorinostat in Combination with Cyclophosphamide, Etoposide, Prednisone, and Rituximab for Elderly Patients with Relapsed Diffuse Large B-Cell Lymphoma
Straus, David, MD

[Protocol 08-045]
A Phase I/IIA Study of Pralatrexate and Gemcitabine with Vitamin B12 and Folic Acid Supplementation in Patients with Relapsed or Refractory Lymphoma
Horwitz, Steven, MD

[Protocol 07-062]
A Phase I/IIa Study Evaluating ABT-263 in Patients with Relapsed or Refractory Lymphoid Malignancies
Gerecitano, John, MD, PhD

[Protocol 07-048]
A Phase II Study of Dose-Escalated Rituximab and ICE for Patients with Primary Refractory and Poor-Risk Relapsed Aggressive B-cell Non-Hodgkin's Lymphoma Undergoing Second-Line Therapy Prior to Stem Cell Transplantation
Moskowitz, Craig, MD

[Protocol 03-075]
A Phase II Study of GM-CSF (Sargramostim) and Rituximab Following Autologous Transplantation for Relapsed Follicular Lymphoma
Moskowitz, Craig, MD

[Protocol 07-085]
A Phase II Study of Rituximab, Methotrexate, Procarbazine and Vincristine Followed by High-Dose Chemotherapy with Autologous Stem Cell Rescue in Newly Diagnosed Primary CNS Lymphoma
Abrey, Lauren, MD

[Protocol 04-129]
A Phase II Study of Romidepsin in Progressive or Relapsed Peripheral T-Cell Lymphoma Following Prior Systemic Therapy
Horwitz, Steven, MD

[Protocol 07-095]
A Phase II Trial of Doxorubicin, Rituximab, Cyclophosphamide, Vincristine, and Prednisone (DR-COP) in Patients with Newly Diagnosed AIDS-Associated B-Cell Non-Hodgkin's Lymphoma
Noy, Ariela, MD

[Protocol 07-084]
A Phase II Trial of Liposomal Doxorubicin (Doxil^®) Followed by Bexarotene (Targretin^®) in Advanced Cutaneous T-Cell Lymphoma
Straus, David, MD

[Protocol 05-098]
A Phase Ib Study of SGN-40 with Rituximab and Gemcitabine for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Moskowitz, Craig, MD

[Protocol 08-078]
A Study Evaluating the Effectiveness of Leuprolide for Enhancing Immune Function After Autologous Stem Cell Transplantation
Landau, Heather, MD

[Protocol 07-046]
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Offit, Kenneth, MD

[Protocol 00-069]
Biaxin (Clarithromycin)-Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
Portlock, Carol, MD

[Protocol 07-038]
Cyclophosphamide, Fludarabine, and Total Body Irradiation Followed by the Transplantation of Unrelated Double-Unit Donor Umbilical Cord Blood Grafts for Patients with Hematological Malignancy
Barker, Juliet, MBBS

[Protocol 06-014]
Phase I Study of Xenogeneic CD20 DNA Vaccination in Patients with B-cell Lymphoma
Palomba, M. Lia, MD

[Protocol 07-100]
Prospective Phase II Study of R-CODOX-M/IVAC, including Central Nervous System Penetration and Intensive Intrathecal Prophylaxis, in HIV-associated Burkitt's and Atypical Burkitt's Lymphoma
Noy, Ariela, MD

[Protocol 07-033]
Risk-Adapted Therapy for Patients With Untreated Low-Intermediate Risk, High-Intermediate Risk, or High Risk Diffuse Large B-Cell Lymphoma
Moskowitz, Craig, MD

[Protocol 08-026]
Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated with Radiation Therapy and Chemotherapy
Correa, Denise, PhD

[Protocol 06-162]

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2009 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org